-
The VIPR-1 trial (Visualizing Ischemia in the Pancreatic Remnant): Assessing the role of intraoperative indocyanine green perfusion in predicting postoperative pancreatic leaks and fistulas: Protocol for a phase II clinical trial
Surgery of the pancreas has come a long way since its inception; however, postoperative morbidity is still high. Pancreatic leaks and fistulas are common complications in patients undergoing surgery to remove the pancreas. Fistulas delay subsequent oncological care after surgery and prolong the hospital stay. Hypoperfusion of the pancreas has been proposed as one factor… →
-
GTM 152: What’s Actually Working in GTM Right Now: Lessons from Centari, Atrix AI, & Gaiia
The GTM Podcast is available on any major directory, including: Apple Podcasts Spotify YouTube What’s actually working in go-to-market right now? In this live panel from the GTM Fund AGM, three early-stage leaders from three exceptional companies—Centari, Atrix AI, and Gaiia—break down how they’re closing enterprise deals in some of the most challenging verticals: legal,… →
-
A Coding Implementation for Creating, Annotating, and Visualizing Complex Biological Knowledge Graphs Using PyBEL
«`html A Coding Implementation for Creating, Annotating, and Visualizing Complex Biological Knowledge Graphs Using PyBEL In this tutorial, we explore how to leverage the PyBEL ecosystem to construct and analyze rich biological knowledge graphs directly within Google Colab. We begin by installing all necessary packages, including PyBEL, NetworkX, Matplotlib, Seaborn, and Pandas. We then demonstrate… →
-
BAAI Launches OmniGen2: A Unified Diffusion and Transformer Model for Multimodal AI
«`html BAAI Launches OmniGen2: A Unified Diffusion and Transformer Model for Multimodal AI The Beijing Academy of Artificial Intelligence (BAAI) has introduced OmniGen2, an open-source multimodal generative model that builds upon its predecessor, OmniGen. This next-generation architecture integrates text-to-image generation, image editing, and subject-driven generation within a single transformer framework. Key innovations include the decoupling… →
-
Intermediate-Dose Cytarabine as Postinduction AML Therapy
CONCLUSIONS: Our trial shows noninferior outcomes in patients 18 to 60 years of age with newly diagnosed AML treated with low- versus high-dose cytarabine; this occurred with similar or lower toxicities. (Funded by the Regional Clinical Research Office, Angers and others; EudraCT number, 2014-000699-24; ClinicalTrials.gov number, NCT02416388.). →
-
ByteDance Researchers Introduce ProtoReasoning: Enhancing LLM Generalization via Logic-Based Prototypes
«`html ByteDance Researchers Introduce ProtoReasoning: Enhancing LLM Generalization via Logic-Based Prototypes Understanding the Target Audience The target audience for the ProtoReasoning framework includes AI researchers, business managers in tech, and data scientists interested in the application of large language models (LLMs) in various domains. They typically face challenges in achieving effective model generalization across different… →
-
New from Chinese Academy of Sciences: Stream-Omni, an LLM for Cross-Modal Real-Time AI
New from Chinese Academy of Sciences: Stream-Omni, an LLM for Cross-Modal Real-Time AI Understanding the Target Audience The primary audience for Stream-Omni includes AI researchers, business leaders in technology, and decision-makers in industries leveraging AI for multimodal applications. Their pain points often revolve around: Challenges in integrating diverse data modalities (text, vision, speech) Need for… →
-
Announcing The Winners of the First Perception Challenge for Bin-Picking (BPC)
OpenCV and sponsors at Intrinsic, BOP, and University of Hawaiʻi at Mānoa are excited to announce the prize winners of the first Perception Challenge for Bin-Picking, first revealed at CVPR during the Perception for Industrial Robotics workshop. Beginning in February 2025, this challenge had over $60,000 at stake and over 450 teams vying for a… →
-
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS
CONCLUSION: Although patients receive an early etiological diagnosis, the cost-utility after 6 months is not favorable for amyloid-PET. The cost-utility will need to be reassessed when considering amyloid-PET to select patients for anti-amyloid biologics. →
-
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial
CONCLUSIONS: Tumor size at diagnosis remained an independent prognostic factor in patients with TNBC and HER2-positive breast cancer with RD after NAST. In contrast, patients achieving pCR had excellent outcomes regardless of initial disease extent, supporting the relevance of pCR as a surrogate endpoint in breast cancer. →
